Compounds > 5-(4-acetamidophenyl)pyrazin-2(1h)-one
Page last updated: 2024-09-03

5-(4-acetamidophenyl)pyrazin-2(1h)-one and flosequinan

5-(4-acetamidophenyl)pyrazin-2(1h)-one has been researched along with flosequinan in 1 studies

Compound Research Comparison

Studies
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)		Trials
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)		Recent Studies (post-2010)
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)		Studies
(flosequinan)		Trials
(flosequinan)		Recent Studies (post-2010) (flosequinan)
38001394410

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beleta, J; Berga, P; Bou, J; Cardelús, I; Fernández, AG; Gristwood, RW; Llenas, J1

Other Studies

1 other study(ies) available for 5-(4-acetamidophenyl)pyrazin-2(1h)-one and flosequinan

ArticleYear
Studies on the cardiac actions of flosequinan in vitro.
    British journal of pharmacology, 1992, Volume: 105, Issue:4

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Action Potentials; Animals; Carbachol; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Pyrazines; Pyrrolidinones; Quinolines; Rolipram; Vasodilator Agents

1992